Age-related impairments of immune responsiveness result in reduced efficacy of influenza vaccination in older adults. The overall objective of this NIH-funded project led by Marian Kohut is to develop an efficacious influenza nanovaccine for older populations, and to understand the mechanisms by which rational selection of biomaterials and co-adjuvants in vaccines can enhance immune capabilities of aged individuals.